RecruitingNot ApplicableNCT07612644

Hemorrhage Elimination During Lumbar Puncture Using Ultrasound Measurements (HELPUS)


Sponsor

Vanderbilt University Medical Center

Enrollment

80 participants

Start Date

May 16, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This is a clinical trial to determine the extent to which ultrasound-assisted lumbar puncture using a standardized procedure, including use of ultrasound to ascertain the presence of cerebrospinal fluid (CSF) at L3 - L5 and the optimal needle insertion distance, increases the acquisition rate of CSF that is interpretable for patient management.


Eligibility

Min Age: 1 DayMax Age: 12 Months

Inclusion Criteria3

  • \- Neonates and infants (< 12 months)
  • Hemodynamically stable
  • Undergoing a lumbar puncture for diagnostic testing

Exclusion Criteria3

  • \- Infants > 12 months and 1 day
  • Signs of clinical instability
  • Known spinal anomalies (e.g., spina bifida, meningomyelocele) or previous spinal surgery

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEultrasound contrast

Ultrasound of spinal canal without contrast. We included the term "ultrasound contrast" because the choices were limited.


Locations(1)

Vanderbilt University Medical Center

Nashville, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07612644


Related Trials